Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Liddicoat, Johnathon
28  Ergebnisse:
Personensuche X
?
1

European patent protection for medical uses of known produc..:

Aboy, Mateo ; Liddell, Kathleen ; Jordan, Matthew..
Nature Biotechnology.  40 (2022)  4 - p. 465-471 , 2022
Link: https://doi.org/10.1038/..
 
?
2

Repositioning Generic Drugs: Empirical Findings and Policy ..:

Liddicoat, Johnathon ; Liddell, Kathleen ; Darrow, Jonathan...
IIC - International Review of Intellectual Property and Competition Law.  53 (2022)  9 - p. 1287-1322 , 2022
Link: https://doi.org/10.1007/..
 
?
3

Has the EU Incentive for Drug Repositioning Been Effective?..:

Liddicoat, Johnathon ; Liddell, Kathleen ; Aboy, Mateo.
IIC - International Review of Intellectual Property and Competition Law.  52 (2021)  7 - p. 825-851 , 2021
Link: https://doi.org/10.1007/..
 
?
4

An empirical study of large, human biobanks: intellectual p..:

Jordan, Matthew ; Liddicoat, Johnathon ; Liddell, Kathleen
Journal of Law and the Biosciences.  8 (2021)  1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
5

Mapping the European patent landscape for medical uses of k..:

Aboy, Mateo ; Liddell, Kathleen ; Liddicoat, Johnathon..
Nature Biotechnology.  39 (2021)  11 - p. 1336-1343 , 2021
Link: https://doi.org/10.1038/..
 
?
6

One year after Vanda, are diagnostics patents transforming ..:

Aboy, Mateo ; Crespo, Cristina ; Liddell, Kathleen...
Nature Biotechnology.  38 (2020)  3 - p. 279-283 , 2020
Link: https://doi.org/10.1038/..
 
?
7

Reply to C.D. Richter:

Liddicoat, Johnathon ; Liddell, Kathleen ; McCarthy, Arlie H....
European Journal of Human Genetics.  28 (2020)  5 - p. 537-538 , 2020
Link: https://doi.org/10.1038/..
 
?
8

Mayo's impact on patent applications related to biotechnolo..:

Aboy, Mateo ; Crespo, Cristina ; Liddell, Kathleen..
Nature Biotechnology.  37 (2019)  5 - p. 513-518 , 2019
Link: https://doi.org/10.1038/..
 
?
9

How does emerging patent case law in the US and Europe affe..:

Aboy, Mateo ; Liddell, Kathleen ; Crespo, Cristina...
Nature Biotechnology.  37 (2019)  10 - p. 1118-1125 , 2019
Link: https://doi.org/10.1038/..
 
?
10

Continental drift? Do European clinical genetic testing lab..:

Liddicoat, Johnathon ; Liddell, Kathleen ; McCarthy, Arlie H....
European Journal of Human Genetics.  27 (2019)  7 - p. 997-1007 , 2019
Link: https://doi.org/10.1038/..
 
?
11

Was the Myriad decision a 'surgical strike' on isolated DNA..:

Aboy, Mateo ; Crespo, Cristina ; Liddell, Kathleen..
Nature Biotechnology.  36 (2018)  12 - p. 1146-1149 , 2018
Link: https://doi.org/10.1038/..
 
?
12

When can exclusive licensees initiate patent infringement p..:

Liddicoat, Johnathon ; de Werra, Jacques
Journal of Intellectual Property Law & Practice.  14 (2018)  1 - p. 2-4 , 2018
Link: https://doi.org/10.1093/..
 
?
13

Standing on the Edge – What Type of "Exclusive Licensees" S..:

Liddicoat, Johnathon
IIC - International Review of Intellectual Property and Competition Law.  48 (2017)  6 - p. 626-651 , 2017
Link: https://doi.org/10.1007/..
 
?
14

After Myriad, what makes a gene patent claim 'markedly diff..:

Aboy, Mateo ; Liddicoat, Johnathon ; Liddell, Kathleen..
Nature Biotechnology.  35 (2017)  9 - p. 820-825 , 2017
Link: https://doi.org/10.1038/..
 
?
15

Myriad's impact on gene patents:

Aboy, Mateo ; Liddell, Kathleen ; Liddicoat, Johnathon.
Nature Biotechnology.  34 (2016)  11 - p. 1119-1123 , 2016
Link: https://doi.org/10.1038/..
 
1-15